Weston Daniel
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$5.6MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $5.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 20, 2026 | NIH | SBIR Phase II NanoDiscs for Immune Modulation in Celiac Disease | $1.0M | EVOQ THERAPEUTICS, INC. |
| Sep 19, 2025 | NIH | SBIR Phase II NanoDiscs for Immune Modulation in Celiac Disease | $1.1M | EVOQ THERAPEUTICS, INC. |
| Jun 18, 2025 | NIH | SBIR Phase II Novel immunotherapy against MOG antibody disease | $989K | EVOQ THERAPEUTICS, INC. |
| Aug 21, 2024 | NIH | SBIR Phase II New approach for immune modulation against T1D | $756K | EVOQ THERAPEUTICS, INC. |
| Jul 11, 2024 | NIH | SBIR Phase II Novel immunotherapy against MOG antibody disease | $1.0M | EVOQ THERAPEUTICS, INC. |
| Sep 19, 2023 | NIH | SBIR Phase II New approach for immune modulation against T1D | $762K | EVOQ THERAPEUTICS, INC. |
Peer ranks
Federal funding#225
Awards as PI#315
Patents#273
Companies
- EVOQ THERAPEUTICS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.